Aaron Fullerton

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake et al. · Journal of Medicinal Chemistry · 2021 · 159 citations

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico</i> Strategy

Zhihua Li, Gary R. Mirams, Takashi Yoshinaga et al. · Clinical Pharmacology & Therapeutics · 2019 · 106 citations · Full text

Towards in vitro models for reducing or replacing the use of animals in drug testing

David M. Stresser, Anna K. Kopec, Philip Hewitt et al. · Nature Biomedical Engineering · 2023 · 75 citations

Animal Testing, Xenotransplantation, Preclinical Drug Evaluation +11

Drug‐induced allergic hepatitis develops in mice when myeloid‐derived suppressor cells are depleted prior to halothane treatment

Mala Chakraborty, Aaron Fullerton, Kenrick Semple et al. · Hepatology · 2015 · 65 citations · Full text

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma

Satoko Kakiuchi-Kiyota, Thorsten Ross, Heidi Ackerly Wallweber et al. · Leukemia · 2022 · 39 citations

Hematological Malignancy, Tumor Biology, Malignant Blood Disorder +7